ORIGINAL RESEARCH
Published on 10 Mar 2025
Semaglutide promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells through activation of the Wnt/LRP5/β-catenin signaling pathway
doi 10.3389/fphar.2025.1539411
- 156 views